{"url_path":"/sec/mobi/10-q/2026/item-5","section_key":"item-5","section_title":"Item 5 Other Information.","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-06-04","source_url":"https://www.sec.gov/Archives/edgar/data/1489993/0001193125-26-257552-index.html","accession_number":"0001193125-26-257552","cik":"0001489993","ticker":"MOBI","issuer_name":"Mobia Medical, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1489993/0001193125-26-257552-index.html","primary_entity_key":"0001489993","primary_entity_name":"Mobia Medical, Inc."},"word_count":56,"has_tables":true,"body_markdown":"Item 5. Other Information.\n\n(a) None.\n\n(b) None.\n\n(c) During the three months ended March 31, 2026, none of our officers or directors (as defined in Rule 16a-1 under the Exchange Act) adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement” (as those terms are defined in Item 408 of Regulation S-K)."}